Your session is about to expire
← Back to Search
Device
AngioSafe Peripheral CTO Crossing System for Peripheral Arterial Disease (RESTOR-1 Trial)
N/A
Waitlist Available
Led By Subhash Banerjee, MD
Research Sponsored by AngioSafe, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
Summary
This trial is testing a new device that helps doctors clear blocked arteries in the legs. It aims to show that the device is safe and works well for patients with severe artery blockages. The study will include at least 70 patients and will monitor them for a short period.
Eligible Conditions
- Peripheral Arterial Disease
- Peripheral Artery Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Procedural Success of AngioSafe Peripheral CTO Crossing System
Technical Success of AngioSafe Peripheral CTO Crossing System
Trial Design
1Treatment groups
Experimental Treatment
Group I: AngioSafe Peripheral CTO Crossing System ProcedureExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
AngioSafe, Inc.Lead Sponsor
Veranex, Inc.UNKNOWN
Subhash Banerjee, MDPrincipal InvestigatorNorth Texas Veterans Healthcare System
18 Previous Clinical Trials
4,018,411 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
14,253 Patients Enrolled for Peripheral Arterial Disease
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger